4x founder

Uri Lopatin

“Lead with why” = because (patients + science)

Founder

Pardes Biosciences· Summer 2020 🇺🇸 San Francisco, California, United States

in LinkedIn

2026Board Member· Rubedo Life Sciences

Founder · since 2012

Company

Rubedo Life Sciences

Role

Board Member

current

Stage

—

no public source

Raised

—

no public source

Based

—

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

Pardes Biosciences

We break viruses

Summer 2020

Experience

Career

Ukko
CEO · 2024 – Present
2024
Khosla Ventures
Venture Partner · 2026 – Present
2026
Khosla Ventures
Operating Partner · San Francisco Bay Area · 2023 – 2026
2023
Rubedo Life Sciences
Board Member · 2026 – Present
2026
Ukko
CEO · 2024 – Present
2024
Edmund Hillary Fellowship (EHF)
Fellow · 2020 – Present
2020
Pardes Biosciences
Founder
Founder, Board Member, Strategic and Scientific Advisor · 2022 – 2023
2022
Pardes Biosciences
Founder
Founder, CEO and President · San Francisco Bay Area · 2020 – 2022
2020
Y Combinator
Expert - Bio · San Francisco Bay Area · 2020 – 2023
2020
Y Combinator
Visiting Partner · San Francisco Bay Area · 2019 – 2020
2019
Assembly Biosciences, Inc.
Scientific & Strategic Advisor · San Francisco Bay Area · 2019 – 2022
2019
Assembly Biosciences, Inc.
Co-founder
Co-Founder & Chief Medical Officer · San Francisco/IN · 2012 – 2019
2012
StartX Med
Mentor · 2012 – 2019
2012
Thiel 20 under 20 Fellowship
Mentor · 2013 – 2016
2013
Yosera
Founder
Founder & CEO · San Francisco · 2012 – 2015
2012
The Center for Biosecurity - UPMC
Fellow - Emerging Leaders in Biosecurity Initiative · 2013 – 2015
2013
Assembly Pharmaceuticals
Co-founder
Co-Founder/Chief Medical Officer/VP R&D · 2012 – 2014
2012
Gilead Sciences
Senior Director, Clinical and Translational Research · 2010 – 2012
2010
Roche Pharmaceuticals
Translational Medicine Leader · Palo alto, Ca · 2008 – 2010
2008
Schering-Plough Research Institute
Associate Director: Hepatology · 2007 – 2008
2007
National Institutes of Health
Physician-Scientist: Infectious Disease Fellowship and Mucosal Immunology Research · 2003 – 2007
2003
NYU
Resident · 2002 – 2003
2002
UMDNJ-NJMS
Medical Student · 1994 – 2000
1994
NIH
CRTP Fellow · Bethesda, Maryland · 1996 – 1997
1996

Bio

Co-founder and the Chief Medical Officer of Assembly Pharma (2012) and CMO/VP R&D for Assembly Biosciences (f\k\a Ventrus Bioscience), which reverse merged with Assembly Pharma in 2014. He helped ASMB raise > $300M to move 2 generations of novel HBV meds into Ph 1 and Ph 2 clinical studies. Uri has held roles at Schering Plough, Roche, and Gilead Science, and received medical training at UMDNJ, NYU and the NIH. Uri was a visiting partner at YC before he started Pardes to cure COVID-19